First District U.S. Rep.
Congress has passed a series of reforms intended to lower prescription drug prices, though some industry analysts say the impact may be less than expected.
The reforms affect the operation of pharmacy benefit managers, companies that negotiate prescription drug prices for health insurers, and employer-sponsored health plans.
Lawmakers put tough questions to UnitedHealth Group CEO Stephen Hemsley on Jan. 21, challenging the executive on his pay and demanding answers on whether the Eden Prairie-based company drives up costs through its massive size while subjecting patients to wrongful claims denials.
WASHINGTON (WJHL) — Congresswoman Diana Harshbarger has reintroduced legislation to help those w
WASHINGTON, D.C. – U.S. Rep. Diana Harshbarger, R-Tenn., re-introduced a bill Thursday to remove the waiting period for terminally ill patients’ access to Social Security program benefits, according to a press release.
Congresswoman Diana Harshbarger, R-Tenn., this week highlighted bipartisan legislation to strengthen Medicare’s home infusion benefit and expand access to care for rural patients during a House Energy and Commerce Health Subcommittee hearing.
A bipartisan bill recently reintroduced in congress could reshape pharmacy reimbursements across the nation.
The legislation is filed around PBMs or Pharmacy Benefit Managers - these are the middlemen within the prescription drug supply chain. PBMs essentially negotiate pricing with drug manufacturers and secure reimbursements for pharmacies.
Lawmakers and healthcare leaders say, for years, these PBMs have been driving up drug costs and gouging community pharmacists.
